A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO)

DSpace Repository

A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO)

Author: Turner, Nicholas C.; Telli, Melinda L.; Rugo, Hope S.; Mailliez, Audrey; Ettl, Johannes; Grischke, Eva-Maria; Mina, Lida A.; Balmana, Judith; Fasching, Peter A.; Hurvitz, Sara A.; Wardley, Andrew M.; Chappey, Colombe; Hannah, Alison L.; Robson, Mark E.
Tübinger Autor(en):
Grischke, Eva-Maria
Published in: Clinical Cancer Research (2019), Bd. 25, H. 9, S. 2717-2724
Verlagsangabe: Amer Assoc Cancer Research
Language: English
Full text: http://dx.doi.org/10.1158/1078-0432.CCR-18-1891
ISSN: 1557-3265
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)